By Anthony O. Goriainoff
Scancell Holdings said Sath Nirmalananthan has been appointed chief financial officer with immediate effect.
The London-listed biopharmaceutical company said Tuesday that Nirmalananthan has over 15 years experience in healthcare after having worked for FTSE and NASDAQ-listed companies. It added that Nirmalananthan was CFO for Europe, Middle East and Africa at Prenetics, and has held senior positions at BTG.
Shares at 0729 GMT were flat at 9.75 pence.
Write to Anthony O. Goriainoff at [email protected]
Read the full article here
